Testosterone therapy and prostate cancer--safety concerns are well founded.
about
Molecular effects of supraphysiological doses of doping agents on health.The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.Leydig cell stem cells: Identification, proliferation and differentiation.Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.Transplantation of alginate-encapsulated seminiferous tubules and interstitial tissue into adult rats: Leydig stem cell differentiation in vivo?Transdifferentiation of adult rat stem Leydig cells into prostatic and uterine epithelium, but not epidermis.Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet.
P2860
Q38383101-8B7752C6-B9ED-4F3D-83B7-4FD1F641686DQ38927944-8B88290D-418D-483F-A6B3-7D875F20E79EQ38941518-AFE89DD2-3759-44BD-9AE4-50A41E4B377FQ40501272-8A861FC0-0F38-484C-AD27-B4DC510A4981Q46421175-FBC55115-160D-4DD2-8153-6D7A6626720FQ47600015-129C2083-4212-47FD-BAB2-9DE56ECF8B83Q50102117-1DDEE269-1818-4791-A9A0-3955FE3A76AF
P2860
Testosterone therapy and prostate cancer--safety concerns are well founded.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Testosterone therapy and prostate cancer--safety concerns are well founded.
@en
Testosterone therapy and prostate cancer--safety concerns are well founded.
@nl
type
label
Testosterone therapy and prostate cancer--safety concerns are well founded.
@en
Testosterone therapy and prostate cancer--safety concerns are well founded.
@nl
prefLabel
Testosterone therapy and prostate cancer--safety concerns are well founded.
@en
Testosterone therapy and prostate cancer--safety concerns are well founded.
@nl
P2860
P356
P1476
Testosterone therapy and prostate cancer--safety concerns are well founded.
@en
P2860
P2888
P356
10.1038/NRUROL.2014.338
P407
P577
2015-01-01T00:00:00Z